tirzepatide discontinuation for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide Mechanism of Weight Loss

For example, obesity is associated with a higher risk of developing several cancers, including kidney and liver cancer

This combination of defective mitophagy and impaired protein import exacerbates the proteostatic stress, promotes aggregate formation, and further compromises mitochondrial dynamics

Insulin resistance can be a key contributor to all these issues and many more

Those with low baseline weight or minimal metabolic dysfunction may see slower percentage changes

Women with PCOS may actually experience improved fertility as they lose weight on semaglutide, making reliable contraception more important, not less, during treatment

, , , ( - ) - , , , ,